Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state.

TitleFeasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state.
Publication TypeJournal Article
Year of Publication2012
AuthorsQuon, BS, Patrick, DL, Edwards, TC, Aitken, ML, Gibson, RL, Genatossio, A, McNamara, S, Goss, CH
JournalJ Cyst Fibros
Volume11
Issue3
Pagination216-22
Date Published2012 May
ISSN1873-5010
KeywordsAdolescent, Adult, Child, Cystic Fibrosis, Equipment Design, Feasibility Studies, Female, Follow-Up Studies, Forced Expiratory Volume, Health Status, Humans, Male, Monitoring, Physiologic, Motor Activity, Walking, Young Adult
Abstract

BACKGROUND: Evaluation of physical activity is integral to the assessment of daily physical function and a potential objective outcome measure for clinical trials. We evaluated the feasibility of using pedometers to measure physical activity in adolescents and adults with cystic fibrosis (CF) and assessed the responsiveness of its measurement to changes in health state.

METHODS: Participants were recruited through two CF clinics in Seattle, WA. Subjects were instructed to use their pedometer for at least one ill and two well periods (each lasting 7 days). Step rate was calculated as steps per hour of use. Daily symptoms were also recorded using the CF Respiratory Symptom Diary (CFRSD). Generalized estimating equation linear regression was used to compare mean step rate between health states and by self-reported symptom category.

RESULTS: We enrolled 30 CF patients with a mean (±SD) age of 22 (±7) years and a mean forced expiratory volume in 1s (FEV(1)) of 57% (±25%) predicted. The mean period step rate increased from 397 (95% CI 324-497) steps/hour when ill to 534 (95% CI 413-654) steps/hour when well (p=0.015). Pedometer-recorded step rate also correlated with self-reported physical activity items on the CFRSD.

CONCLUSION: Step rate measured with a pedometer correlates significantly with changes in health status and self-reported activity, and could be used as an outcome measure in CF.

DOI10.1016/j.jcf.2011.12.002
Alternate JournalJ. Cyst. Fibros.
PubMed ID22226414
PubMed Central IDPMC4197911
Grant ListK23 HL 72017 / HL / NHLBI NIH HHS / United States
P30 DK089507 / DK / NIDDK NIH HHS / United States
RR-00037-39 / RR / NCRR NIH HHS / United States
UL1 TR000423 / TR / NCATS NIH HHS / United States